Biowa,
It's not that surprising they went into the 20's if you read their nice calm release from yesterday:
Colorado Pharmaceutical Co. Makes Cancer Drug History;
MEDIA ADVISORY: PRESS CONFERENCE 11/17
Ribozyme Pharmaceuticals, Inc. (RPI), the Boulder CO pharmaceutical and biotech company, will disclose important corporate and product news concerning its unique cancer drug, Angiozyme(TM):
<snip>
Angiozyme -- it's cancer drug -- has made significant progress. Angiozyme is now in human clinical trials at the Cleveland Clinic Foundation and has taken an important step forward ... making both clinical history and industry news. RPI CEO & President, Ralph E. Christoffersen, Ph.D., and other senior RPI staff, will explain Angiozyme and its recent history-making leap, an achievement which may be of great significance to cancer patients everywhere.
"Cancer drug history" and "history-making leap" for a drug that seems to have never been tried on cancer patients? (I'm not real certain on this, but it looked to me that the Phase I was in healthy volunteers, and they are only now starting on a Phase II).
Peter
|
